🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and immune response of ...
Status
Completed
Location
University of Rochester
Start Date
2000-11
Trial ID
NCT00133549
Treatments Being Tested
TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blin...
Status
Unknown
Location
• Unidade de Ensaios Clínicos para Imunobiológicos/Instituto de Tecnologia em Imunobiológicos de Bio-Manguinhos/Fiocruz
Start Date
2018-09-25
Trial ID
NCT02858570
Treatments Being Tested
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity and safety of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-25
Trial ID
NCT02184572
Treatments Being Tested
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
This study is an open-label combined randomized double-blind, positive cont...
Status
Completed
Location
Henan Center for Diseases Control and Prevention
Start Date
2023-01-03
Trial ID
NCT05092386
The purpose of this study is to determine whether an early schedule of a co...
Status
Completed
Location
Menzies School of Health Research
Start Date
2011-08
Trial ID
NCT01174849
Treatments Being Tested
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
The purpose of this study was to compare the immunogenicity and describe th...
Status
Completed
Location
Birmingham Pediatric Associates Site Number : 8400026
Start Date
2018-04-25
Trial ID
NCT03537508
The purpose of this study in healthy toddlers who have not previously been ...
Status
Completed
Location
Werderstrasse 3
Start Date
2008-03
Trial ID
NCT00617760